Arteris (NASDAQ:AIP) VP Sells $51,550.00 in Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) VP Paul Alpern sold 5,000 shares of the business’s stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $10.31, for a total value of $51,550.00. Following the sale, the vice president directly owned 73,587 shares in the company, valued at $758,681.97. This trade represents a 6.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Arteris Stock Down 2.5%

NASDAQ:AIP opened at $10.98 on Monday. The stock has a fifty day simple moving average of $9.65 and a 200 day simple moving average of $8.43. The firm has a market capitalization of $468.30 million, a price-to-earnings ratio of -13.39 and a beta of 1.45. Arteris, Inc. has a 1-year low of $5.46 and a 1-year high of $14.29.

Arteris (NASDAQ:AIPGet Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, meeting analysts’ consensus estimates of ($0.11). Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. The company had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts predict that Arteris, Inc. will post -0.73 earnings per share for the current year.

Analyst Ratings Changes

AIP has been the subject of several recent analyst reports. TD Cowen raised their target price on Arteris from $12.00 to $15.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a research report on Saturday, September 27th. Finally, Wall Street Zen upgraded Arteris from a “sell” rating to a “hold” rating in a report on Monday, September 15th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $15.00.

View Our Latest Research Report on AIP

Institutional Investors Weigh In On Arteris

Institutional investors have recently made changes to their positions in the company. Acadian Asset Management LLC grew its stake in shares of Arteris by 40.6% in the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company’s stock valued at $6,222,000 after buying an additional 260,277 shares in the last quarter. AQR Capital Management LLC bought a new stake in Arteris in the first quarter worth approximately $1,621,000. Federated Hermes Inc. boosted its holdings in Arteris by 97.2% in the first quarter. Federated Hermes Inc. now owns 327,119 shares of the company’s stock worth $2,260,000 after purchasing an additional 161,241 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of Arteris by 9.6% in the second quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company’s stock worth $15,602,000 after buying an additional 142,936 shares during the last quarter. Finally, Next Century Growth Investors LLC boosted its stake in shares of Arteris by 46.4% during the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company’s stock worth $2,817,000 after acquiring an additional 129,143 shares in the last quarter. 64.36% of the stock is currently owned by institutional investors and hedge funds.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Recommended Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.